1) Hepatocellular carcinoma
肝细胞肝癌
1.
Relationship Between Expression of PEG10 Gene and Apoptosis in Human Hepatocellular Carcinoma;
PEG10基因在肝细胞肝癌中表达及其与凋亡的关系
2.
Clinico-pathological significance of intratumoral microvessel density and estrogen receptor expression in hepatocellular carcinoma;
肝细胞肝癌微血管密度与雌激素受体表达的临床病理意义
3.
Expression of PTEN in hepatocirrhosis and hepatocellular carcinoma and its clinical significance;
肝硬化、肝细胞肝癌中PTEN的表达及其临床意义
2) HCC
肝细胞肝癌
1.
Objective To study the significance of the expressing of integrin-β1(CD29),vascular cell adhesion molecule-1(VCAM-1,CD106) in sinusoid-lemons of the hepatocellular carcinoma(HCC).
目的研究肝细胞肝癌(hepatocellular carcinoma,HCC)血窦样腔隙中中整合素β1亚单位(inte-grin-β1,CD29)、血管细胞粘附分子(vascular cell adhesion molecule-1,VCAM-1,CD106)的表达意义。
2.
Hepatocellular carcinoma (HCC) is one of the most common malignant tumorswith poor prognosis, and China is the area with highest HCC risk.
肝细胞肝癌(Hepatocellular carcinoma, HCC)是一种发病率较高且预后较差的恶性肿瘤,而中国是 HCC 的高发区域。
3.
About 90%-95% cases are hepatocellular carcinoma(HCC).
【背景】原发性肝癌是成年人最常见的恶性肿瘤之一,其中90%-95%为肝细胞肝癌(hepatocellular carcinoma,HCC)。
3) Hepatocelluar carcinoma
肝细胞肝癌
1.
On gene x of hepatitis B virus and hepatocelluar carcinoma;
乙型肝炎病毒x基因与肝细胞肝癌
2.
15 cells) and analyze the significance of Hepatocelluar carcinoma (HCC) prevention & treatment of CP (Compound phyllanthus urinaria L.
15)移植裸鼠(Balb/c-nu mice)HBxAg表达的影响,分析CP对肝细胞肝癌(Hepatocelluar carcinoma,HCC)的防治意义,探讨其对HCC的作用是否与HBxAg表达有关。
3.
Objective: to explore if vasculogenic mimicry (VM) exists in hepatocelluar carcinoma (HCC) and further to investigate its potential mechanism, to explain the clinical significance of VM.
目的:研究肝细胞肝癌(hepatocellular Carcinoma, HCC)中是否存在血管生成拟态(Vasculogenic Mimicry, VM)这一独特的肿瘤血液供应模式及其相关发生发展的分子机制,并进一步阐述这种独特血液供应模式的临床意义。
5) Hepatocellular carcinoma
肝细胞癌
1.
Mcl-1 gene and hepatocellular carcinoma;
Mcl-1基因与肝细胞癌
2.
Expression of Livin and Smac in primary hepatocellular carcinoma tissue;
原发性肝细胞癌组织中Livin和Smac蛋白的表达
3.
Reversal of multidrug resistance of hepatocellular carcinoma by siRNA/mdr1;
RNA干扰逆转肝细胞癌多药耐药
6) hepatoma cell
肝癌细胞
1.
Expression and significance of CD147 and MMP-9 in hepatoma cell line SMMC-7721;
肝癌细胞株SMMC-7721中CD147和MMP-9的表达及意义
2.
Effects of ferromagnetic fluid hyperthermia induced by an alternative magnetic field on hepatoma cell HepG2 in vitro;
铁磁流体联合交变磁场对人肝癌细胞HepG2的影响
3.
Study on apoptosis of human hepatoma cell line hepG2 induced by Paeoniflorin;
芍药甙诱导人肝癌细胞系HepG2凋亡的研究
补充资料：肝复肽 ,肝细胞水解物
药物名称：肝复肽
英文名：Hepatocyte Hydrolysate
别名： 肝复肽 ,肝细胞水解物
外文名：hepatocyte hydrohysate
适应症： 重症肝炎、急性肝炎、慢性肝炎、肝硬化的辅助治疗。
用量用法： 肌肉注射：20 mg bid,一个月为一疗程。静脉注射：40－80mg qd,一个月为一疗程。
规格： 粉剂 20 mg x 5支。
类别：肝胆疾病辅助用药
英文名：Hepatocyte Hydrolysate
别名： 肝复肽 ,肝细胞水解物
外文名：hepatocyte hydrohysate
适应症： 重症肝炎、急性肝炎、慢性肝炎、肝硬化的辅助治疗。
用量用法： 肌肉注射：20 mg bid,一个月为一疗程。静脉注射：40－80mg qd,一个月为一疗程。
规格： 粉剂 20 mg x 5支。
类别：肝胆疾病辅助用药
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条